U.S. flag

An official website of the United States government

NM_001371596.2(MFSD8):c.161del (p.Ser54fs) AND Neuronal ceroid lipofuscinosis 7

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Oct 25, 2017
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000779431.6

Allele description [Variation Report for NM_001371596.2(MFSD8):c.161del (p.Ser54fs)]

NM_001371596.2(MFSD8):c.161del (p.Ser54fs)

Gene:
MFSD8:major facilitator superfamily domain containing 8 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
4q28.2
Genomic location:
Preferred name:
NM_001371596.2(MFSD8):c.161del (p.Ser54fs)
HGVS:
  • NC_000004.12:g.127949841del
  • NG_008657.1:g.21144del
  • NM_001363520.3:c.161delC
  • NM_001363521.3:c.161delC
  • NM_001371590.2:c.26delC
  • NM_001371591.2:c.161delC
  • NM_001371592.2:c.161delC
  • NM_001371593.2:c.161delC
  • NM_001371594.2:c.161delC
  • NM_001371595.1:c.26del
  • NM_001371596.2:c.161delMANE SELECT
  • NM_001410765.1:c.26delC
  • NM_001410766.1:c.161delC
  • NM_152778.4:c.161del
  • NP_001350449.1:p.Ser54Leufs
  • NP_001350449.1:p.Ser54fs
  • NP_001350450.1:p.Ser54Leufs
  • NP_001350450.1:p.Ser54fs
  • NP_001358519.1:p.Ser9Leufs
  • NP_001358519.1:p.Ser9fs
  • NP_001358520.1:p.Ser54Leufs
  • NP_001358520.1:p.Ser54fs
  • NP_001358521.1:p.Ser54Leufs
  • NP_001358521.1:p.Ser54fs
  • NP_001358522.1:p.Ser54Leufs
  • NP_001358522.1:p.Ser54fs
  • NP_001358523.1:p.Ser54Leufs
  • NP_001358523.1:p.Ser54fs
  • NP_001358524.1:p.Ser9fs
  • NP_001358525.1:p.Ser54fs
  • NP_001397694.1:p.Ser9Leufs
  • NP_001397695.1:p.Ser54Leufs
  • NP_689991.1:p.Ser54fs
  • LRG_833t1:c.161del
  • LRG_833t2:c.161del
  • LRG_833:g.21144del
  • LRG_833p1:p.Ser54fs
  • LRG_833p2:p.Ser54fs
  • NC_000004.11:g.128870996del
  • NM_001363520.2:c.161del
  • NM_001363521.2:c.161del
  • NM_001371590.1:c.26del
  • NM_001371591.1:c.161del
  • NM_001371592.1:c.161del
  • NM_001371593.1:c.161del
  • NM_001371594.1:c.161del
  • NM_152778.2:c.161delC
Protein change:
S54fs
Links:
dbSNP: rs1560764227
NCBI 1000 Genomes Browser:
rs1560764227
Molecular consequence:
  • NM_001363520.3:c.161delC - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001363521.3:c.161delC - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001371590.2:c.26delC - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001371591.2:c.161delC - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001371592.2:c.161delC - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001371593.2:c.161delC - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001371594.2:c.161delC - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001371595.1:c.26del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001371596.2:c.161del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001410765.1:c.26delC - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001410766.1:c.161delC - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_152778.4:c.161del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Neuronal ceroid lipofuscinosis 7 (CLN7)
Synonyms:
MFSD8-Related Neuronal Ceroid-Lipofuscinosis
Identifiers:
MONDO: MONDO:0012588; MedGen: C1838571; Orphanet: 168491; Orphanet: 228366; OMIM: 610951

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000916047Illumina Laboratory Services, Illumina
criteria provided, single submitter

(ICSL Variant Classification Criteria 09 May 2019)
Uncertain significance
(Oct 25, 2017)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Illumina Laboratory Services, Illumina, SCV000916047.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The MFSD8 c.161delC (p.Ser54LeufsTer2) variant results in a frameshift and is predicted to result in premature termination of the protein. It was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018) and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score for this variant, it could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene and cDNA change, and amino acid change. No publications were found based on this search. Due to the potential impact of frameshift variants and the lack of clarifying evidence, this variant is classified as a variant of unknown significance but suspicious for pathogenicity for neuronal ceroid-lipofuscinosis.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 9, 2023